Loading...

AstraZeneca PLC

AZN•NYSE
Healthcare
Drug Manufacturers - General
$189.75
$-2.55(-1.33%)
U.S. Market opens in 15h 24m

AstraZeneca PLC (AZN) Stock Overview

Explore AstraZeneca PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap294.1B
P/E Ratio14.34
EPS (TTM)$6.54
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$190.57
3 Months$98.17
1 Year Target$94.29

AZN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AstraZeneca PLC (AZN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $94.29.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.34 and a market capitalization of 294.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.36%
5-Day Change
-6.47%
1-Month Change
2.10%
3-Month Change
6.86%
6-Month Change
15.84%
Year-to-Date (YTD) Change
8.08%
1-Year Change
38.21%
3-Year Change
23.89%
5-Year Change
79.45%
All-Time (Max) Change
1781.75%

Contact Information

https://www.astrazeneca.com
44 20 3749 5000
1 Francis Crick Avenue, Cambridge, NaN, CB2 0AA

Company Facts

94,300 Employees
IPO DateMay 12, 1993
CountryGB
Actively Trading

Frequently Asked Questions